Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: EmbryoFixTM: (L-Arginine, L-Leucine, L-Tyrosine, Magnesium bis-glycinate, L-
Carnitine, Tocotrienol, L-Tryptophan, Zinc acetate 33.67mg equivalent to elemental zinc,
Seleniomethionine,
Sponsors
Challa Kusuma Chowdari
Eligibility
Inclusion criteria
Inclusion criteria: 1)female patient who had unsuccessful(clomiphene/letrozole±Gonadotropins) fertility treatment for past 3 months. 2)Patients with history of systemic gynecological disease that causes infertility were included in the study.
Exclusion criteria
Exclusion criteria: 1)Men whose semen analysis is abnornal. 2)Patient with endometriosis,adenomysis,myoma,mullerian dysgenesis with tubual block, patient with pcod and hyperprolactinemia. 3)patient not willing to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess EmbryoFixTM in improving fertility by estimating serum ß-hCG during the study period of three menstrual cycles.Timepoint: 6 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the endometrial thickness during the study period of three menstrual cycles done at day 3 & day 12-14 of each menstrual cycle.Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactMs Challa Kusuma Chowdari
Srm college of Pharmacy
Outcome results
None listed